Summary of key recommendations
Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults
Class I |
"1.Clinical ASCVD
|
"2.Primary prevention – Primary LDL-C ‡190 mg/dL
|
"3.Primary preventiondDiabetes 40–75 years of age and LDL-C 70–189 mg/dL
|
"4. Primary prevention – No diabetes 40–75 years of age and LDL-C 70–189 mg/dL
|
Class III (Harm) |
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |
Class III (No Benefit) |
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |
Class IIa |
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |
Class IIb |
"1. RECOMMENDATION 1 HERE (Level of Evidence: C)" |
"2. RECOMMENDATION 2 HERE (Level of Evidence: C)" |